Janet Wood­cock calls for in­de­pen­dent in­ves­ti­ga­tion in­to Bio­gen and FDA re­la­tion­ships in un­prece­dent­ed move

In the lat­est stun­ning chap­ter of the Bio­gen Aduhelm saga, act­ing FDA com­mis­sion­er Janet Wood­cock is call­ing for an in­ves­ti­ga­tion in­to the re­la­tion­ships be­tween agency …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER